 | Up a level |
Journal Article
Behrens, F., Rossmanith, T., Kohm, M., Alten, R., Aringer, M., Backhaus, M., Baerwald, C., Burmester, G., Feist, E., Kellner, H., Krger, K., Muller-Ladner, U., Rubbert-Roth, A., Tony, H. -P., Wassenberg, S. and Burkhardt, H. (2016). RITUXIMAB IN COMBINATION WITH LEFLUNOMIDE: RESULTS FROM A MULTICENTER RANDOMIZED PLACEBO CONTROLLED INVESTIGATOR INITIATED CLINICAL TRIAL IN ACTIVE RHEUMATOID ARTHRITIS (AMARA-STUDY). Ann. Rheum. Dis., 75. S. 502 - 503. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
Henkemeier, U., Alten, R., Bannert, B., Baraliakos, X., Behrens, F., Heldmann, F., Kiltz, U., Koehm, M., Koenig, R., Leipe, J., Mueller-Ladner, U., Rech, J., Riechers, E., Rubbert-Roth, A., Schmidt, R. E., Schulze-Koops, H., Specker, C., Tausche, A. -K, Wassenberg, S., Witt, M., Witte, T., Zernicke, J. and Burkhardt, H. (2016). Do we still need clinical studies in rheumatology? Z. Rheumatol., 75 (1). S. 4 - 11. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1435-1250
Koehm, M., Rossmanith, T., Dauth, S., Alten, R., Aringer, M., Backhaus, M., Burmester, G., Feist, E., Kellner, H., Krueger, K., Mueller-Ladner, U., Rubbert-Roth, A., Tony, H-P., Wassenberg, S., Burkhardt, H. and Behrens, F. (2017). IMPACT OF RITUXIMAB IN COMBINATION WITH LEFLUNOMIDE AND RITUXIMAB RETREATMENT WITH TWO DIFFERENT DOSAGES ON PATIENT-REPORTED OUTCOMES: RESULTS FROM A MULTICENTER RANDOMIZED PLACEBO CONTROLLED INVESTIGATOR INITIATED CLINICAL TRIAL IN ACTIVE RHEUMATOID ARTHRITIS (AMARA-STUDY). Ann. Rheum. Dis., 76. S. 565 - 566. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
Koehm, M., Rossmanith, T., Foldenauer, A. C., Kellner, H., Kiltz, U., Rech, J., Burmester, G. R., Kofler, D. M., Brandt-Juergens, J., Jonetzko, C., Burkhardt, H. and Behrens, F. (2022). EFFICACY OF UST IN ACTIVE PSA IS INDEPENDENT FROM CONCOMITANT MTX USE, EVEN IN PATIENTS WITH MORE SEVERE SKIN PSORIASIS: SUBGROUP ANALYSIS FROM A RANDOMIZED PLACEBO-CONTROLLED INVESTIGATOR INITIATED CLINICAL TRIAL. Ann. Rheum. Dis., 81. S. 850 - 852. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
Rech, J., Kleyer, A., Ostergaard, M., Hagen, M., Valor, L., Tascilar, K., Kronke, G., Schonau, V., Kleinert, S., Baraliakos, X., Braun, J., Fleck, M., Rubbert-Roth, A., Behrens, F., Feuchtenberger, M., Zaenker, M., Kofler, D. M., Voll, R., Glaser, C., Hueber, A., Feist, E., Burmester, G. R., Karberg, K., Strunk, J., Canete, J. D. D., Senolt, L., Naredo, E. and Schett, G. (2022). ABATACEPT DELAYS THE DEVELOPMENT OF RA-CLINICAL RESULTS AFTER 18 MONTHS FROM THE RANDOMIZED, PLACEBO-CONTROLLED ARIAA STUDY IN RA-AT RISK PATIENTS. Ann. Rheum. Dis., 81. S. 526 - 528. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060